Navigation Links
Cappella Inc. Secures $17.3 Million Series C Investment
Date:6/14/2009

c point in the company's development. From our perspective, Cappella have a differentiated product offering for the treatment of coronary heart disease. Cappella's impressive management team and top-class scientific advisory board will drive rapid adoption of the Sideguard(TM) Sidebranch stent in Europe and its successful clinical development in the US."

Masashi Kiyomine, Principal at Mitsui & Co. Venture Partners, commented: "We are very pleased to have co-led this important round of financing for Cappella, to support the global commercial success of the Sideguard(TM) Sidebranch stent. With an experienced management team led by Dr. Rosenthal, we believe Cappella is ideally positioned to become the leading provider of innovative solutions for the treatment of bifurcation vascular disease - an area of high unmet medical need."

Dr Wolfgang Oster, Managing Partner at Polytechnos Venture Partners and Chairman of Cappella's Board, noted: "As founding investors of Cappella, we are delighted to close this substantial round of finance for a company which we believe has the potential to lead the field of bifurcation devices. The commercial expertise which the new investors bring to the table in Europe, US and Japan is reassuring and will help to accelerate the company's marketing efforts of its device portfolio. Importantly, the continued participation of our syndicate partners, in particular ACT Venture Capital, in our common cause was a prerequisite to get the company to this exciting value inflection point."

In addition to Dr. Wolfgang Oster, Dr. Art Rosenthal and Dr. Ena Prosser, other Board seats will be held by Masashi Kiyomine, MCVP, Dr. Ascher Shmulewitz company co-founder, Cappella's Vice Chairman Charlie Glass of ACT Venture Capital and Dirk Kanngiesser, Polytechnos Venture Partners.

About Cappella Inc

Cappella, Inc. ("Cappella" or the "Company") is a medical device company
'/>"/>

SOURCE Cappella, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
4. Altheus Therapeutics Secures $3.6 Million in Venture Capital
5. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
6. Dendreon Secures $130 Million Committed Equity Financing Facility
7. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
8. Taligen Therapeutics Secures Series B Financing
9. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
10. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
11. Amarin Secures Global Intellectual Property Rights for Lipid Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
(Date:12/24/2014)... and NEW YORK , Dec. 24, ... company advancing patient care in critical areas, announced the closing ... stock, and warrants to purchase up to an aggregate 3,500,000 ... per share and $.01 per warrant.  The warrants have a ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... DUBLIN and PHILADELPHIA , June 3, ... specialty biopharmaceutical company,announces that its subsidiary Shire LLC has filed a lawsuit ... Anchen Pharmaceuticals,Inc. and Anchen, Inc. (collectively "Anchen") for the infringement of U.S.,Patent ... patent). , , , ...
... , -Proceeds to support acceleration of CYT387 Phase II myelofibrosis study- , ... MISSISSAUGA, ON , June 3 ... raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 ... at no discount to the closing price of the shares on the NYSE ...
... , , , ... Endpoints , , , ... Agency in,2010 , , , ... reproductive medicine, announces positive Phase III data from its,second pivotal study (PEARL I) for its lead product ...
Cached Biology Technology:INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc. 2INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc. 3YM BioSciences raises US$3.2 million in support of JAK 1/2 program 2YM BioSciences raises US$3.2 million in support of JAK 1/2 program 3YM BioSciences raises US$3.2 million in support of JAK 1/2 program 4PregLem Announces Positive Phase III Results for Esmya(TM) 2PregLem Announces Positive Phase III Results for Esmya(TM) 3PregLem Announces Positive Phase III Results for Esmya(TM) 4
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... sectors including technology and tech stocks, releases video from the ... pickpocket and security consultant Apollo Robbins . ... about the Wocket™ biometric smart wallet, a product of NXT-ID, ...
(Date:1/22/2015)... 2015 , Europe,s ... The European Patent Office to present a video retrospective of the ... be featured: Christofer Toumazou and Sophie Wilson   ... winners of the Award   Starting on 22 January ...
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... PITTSBURGH, Feb. 4 Researchers at the University ... $5.6 million federal contract to pursue the continued development ... and small children with congenital or acquired heart disease. ... sophisticated technologies that have saved the lives of older ...
... that the hydrodynamic environment of fish can shape their physical ... Journal of Experimental Biology Web site, was sponsored by ... Catch a glimpse of a fish,s body shape, and you ... look as if they should outpace frilly reef fish and ...
... energy habits and provide immediate feedback on consumption could ... compromising comfort. The new energy-saving ,Wattbox, device is ... improvements supported by a 2.1 million grant from the ... As well as working with standard energy supplies, the ...
Cached Biology News:Pitt-led team gets $5.6 million contract for heart assist device for infants and toddlers 2Pitt-led team gets $5.6 million contract for heart assist device for infants and toddlers 3Research finds water movements can shape fish evolution 2Habit-learning device will lower energy bills under new clean energy cashback scheme 2